|
2025
|
Invention
|
Construct comprising mrna-strand and retinoic acid-inducible gene i (rig-i)-ligand(s), pharmaceut... |
|
|
Invention
|
Use of cellobiofructose and production method thereof. The present invention relates to the use o... |
|
2024
|
Invention
|
Method for generating state-dependent lattices for cold atoms.
A method for generating state-dep... |
|
|
Invention
|
Plasmin-binding vhhs.
The invention relates to a VHH specifically binding to plasmin. The invent... |
|
|
Invention
|
Ribonucleic acid construct capable of inducing an immune response, as well as pharmaceutical comp... |
|
|
Invention
|
Method for the stimulation of t cells with il-4 and tnf alpha. The present invention relates to m... |
|
|
Invention
|
Aptamers for targeted activation of t cell-mediated immunity.
Compositions comprising aptamers, ... |
|
|
Invention
|
Nucleic acid-based assembly and uses thereof.
The present invention relates to a nucleic acid-ba... |
|
|
Invention
|
Filter device comprising bionic filter element, and method for separating microplastic from fluid... |
|
|
Invention
|
Single-domain antibodies directed against gasdermin d and their use. The present invention is con... |
|
|
Invention
|
Method for producing a diffractive optical element. The invention relates to a method for produci... |
|
|
Invention
|
Inhalation anaesthesia device for improved interactive anaesthesia. The present invention relates... |
|
2023
|
Invention
|
Glycine derivatives with p2x4 receptor-blocking activity as diagnostics and for the treatment of ... |
|
|
Invention
|
Method for determining the autofluorescence of an ocular fundus of an eye by means of optical coh... |
|
|
Invention
|
Method and imaging device for the in-vivo capturing of autofluorescence of an ocular fundus. The ... |
|
|
Invention
|
Method and device for providing mri images relating to at least one part of a patient's body with... |
|
|
Invention
|
Plasmin-binding vhhs |
|
|
Invention
|
Plasmin-binding vhhs. characterized bycharacterized by a thrombotic or embolic state. |
|
|
Invention
|
Mirabegron formulation. The present invention relates to a composition for topical and/or transde... |
|
|
Invention
|
Diagnostics for detecting ecto-5'-nucleotidase (cd73). The present invention relates to radio- an... |
|
|
Invention
|
Antimicrobial composition. The invention relates to antimicrobial compositions and to the use the... |
|
|
Invention
|
Analysis of rna molecules using catalytic nucleic acids.
The present invention relates to a meth... |
|
2022
|
Invention
|
Discontinuous oligonucleotide ligands.
The present invention relates to an oligonucleotide conju... |
|
|
Invention
|
Methods for determining the likelihood of a malignant disease responding to treatment with a phar... |
|
|
Invention
|
Mutated arylsulfatase a.
The present invention pertains to a novel treatment of pathologies caus... |
|
|
Invention
|
Method of pathogen control. The present invention relates to methods for pathogen control, compri... |
|
|
Invention
|
Ruxolitinib for the treatment of prurigo nodularis. This disclosure relates to ruxolitinib, or a ... |
|
|
Invention
|
Ruxolitinib for the treatment of prurigo nodularis.
This disclosure relates to ruxolitinib, or a... |
|
|
Invention
|
Mutated arylsulfatase a with increased stability.
The invention is based on the introduction of ... |
|
|
Invention
|
Mutated arylsulfatase a with increased stability. The invention is based on the introduction of m... |
|
2021
|
Invention
|
Aptamers and use of the aptamers in the diagnosis and treatment of a sars-cov-2 infection. The pr... |
|
|
Invention
|
Method useful in tolerance induction therapy and kits therefore.
The present invention relates i... |
|
|
Invention
|
Aptamers and use of the aptamers in the diagnosis and treatment of a sars-cov-2 infection.
The p... |
|
|
Invention
|
Corona virus spike protein binding compounds. The invention pertains to protein binding compounds... |
|
|
Invention
|
Mrgprx4 agonists and antagonists.
The invention relates to MRGPRX4 receptor agonists and antagon... |
|
|
Invention
|
3-substituted xanthine derivatives as mrgprx4 receptor modulators. The invention relates to MRGPR... |
|
|
Invention
|
Aptamers that target cxcl9.
The present invention relates to an aptamer comprising a nucleotide ... |
|
|
Invention
|
Aptamers that target cxcl9. The present invention relates to an aptamer comprising a nucleotide s... |
|
|
Invention
|
Novel hybrid optical voltage sensors. The invention relates to an optical voltage sensor comprisi... |
|
|
Invention
|
Solid and liquisolid formulations of corallopyronin a.
The present invention relates to a solid ... |
|
|
Invention
|
Liquisolid pharmaceutical formulation and process for manufacturing.
The present invention relat... |
|
|
Invention
|
Solid and liquisolid formulations of corallopyronin a. The present invention relates to a solid o... |
|
|
Invention
|
Liquisolid pharmaceutical formulation and process for manufacturing. The present invention relate... |
|
|
Invention
|
Up-scaled production of microglia-like/-precursor cells and macrophage cells using mesh macrocarr... |
|
|
Invention
|
Method for producing a continuous diffractive optical element, device for carrying out the produc... |
|
2020
|
Invention
|
Induced photoreceptor cells and methods for their production.
A method for producing induced pho... |
|
|
Invention
|
Aptamer and use of the aptamer in the diagnosis and treatment of cancer.
The present invention r... |
|
2019
|
Invention
|
Method of identifying or producing an aptamer for a denatured peptide or protein.
The invention ... |
